Insider Todd Harris holds 5.1% of Tyra Biosciences (TYRA) shares

Rhea-AI Filing Summary

Todd Harris filed a Schedule 13G reporting his beneficial ownership of Tyra Biosciences, Inc. common stock. He reports beneficial ownership of 2,814,379 shares of common stock, representing 5.1% of the class, based on 53,706,357 shares outstanding as of December 31, 2025.

The holdings consist of 1,357,168 shares of common stock held directly and 1,457,211 shares underlying stock options that are currently exercisable or become exercisable within 60 days of December 31, 2025. Harris has sole voting and dispositive power over all 2,814,379 reported shares and no shared voting or dispositive power.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Tyra Biosciences, Inc.

(Name of Issuer)

Common Stock, par value $0.0001 per share

(Title of Class of Securities)

90240B106

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 90240B106

1

Names of Reporting Persons

Todd Harris

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 2,814,379.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 2,814,379.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,814,379.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.1 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Tyra Biosciences, Inc.
(b)	Address of issuer's principal executive offices: 2656 State Street, Carlsbad, CA 92008
Item 2.
(a)	Name of person filing: This statement is filed on behalf of Todd Harris (the "Reporting Person").
(b)	Address or principal business office or, if none, residence: The principal business address of the Reporting Person is c/o Tyra Biosciences, Inc., 2656 State Street, Carlsbad, CA 92008.
(c)	Citizenship: The Reporting Person is a citizen of the United States.
(d)	Title of class of securities: Common Stock, par value $0.0001 per share
(e)	CUSIP No.: 90240B106
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: The ownership information presented herein represents beneficial ownership of Common Stock of the Issuer as of December 31, 2025, based upon 53,706,357 shares of Common Stock outstanding as of December 31, 2025, as provided by the Issuer. The Reporting Person is the beneficial owner of 2,814,379 shares of Common Stock, which consist of (i) 1,357,168 shares of Common Stock held directly by the Reporting Person and (ii) 1,457,211 shares of Common Stock underlying stock options held directly by the Reporting Person that are currently exercisable or may be exercised within 60 days of December 31, 2025.
(b)	Percent of class: 5.1%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 2,814,379
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 2,814,379
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.	Certifications:
	Not Applicable

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Todd Harris

Signature:	/s/ Todd Harris
Name/Title:	Todd Harris
Date:	02/13/2026

FAQ

What ownership in Tyra Biosciences (TYRA) does Todd Harris report on this Schedule 13G?

Todd Harris reports beneficial ownership of 2,814,379 shares of Tyra Biosciences common stock. This represents 5.1% of the company’s outstanding common shares, based on 53,706,357 shares outstanding as of December 31, 2025.

How is Todd Harris’s 2,814,379-share beneficial stake in Tyra Biosciences (TYRA) structured?

Todd Harris’s reported stake includes 1,357,168 shares of common stock held directly. It also includes 1,457,211 shares underlying stock options that are currently exercisable or exercisable within 60 days of December 31, 2025, all counted as beneficially owned.

What percentage of Tyra Biosciences (TYRA) does Todd Harris beneficially own according to this filing?

Todd Harris reports beneficial ownership of 5.1% of Tyra Biosciences’ common stock. This percentage is calculated using 53,706,357 shares outstanding as of December 31, 2025, as provided by the company in the filing.

What voting and dispositive powers does Todd Harris have over his Tyra Biosciences (TYRA) shares?

The filing states that Todd Harris has sole voting power and sole dispositive power over 2,814,379 shares. He reports zero shared voting power and zero shared dispositive power for Tyra Biosciences common stock.

Does this Schedule 13G indicate any group or shared ownership for Tyra Biosciences (TYRA) shares?

No. The Schedule 13G is filed on behalf of Todd Harris alone, and items addressing group status and ownership on behalf of others are marked Not Applicable, indicating no reported group or shared ownership arrangement.

As of what date are Todd Harris’s Tyra Biosciences (TYRA) ownership figures calculated?

The ownership information is calculated as of December 31, 2025. Both the 2,814,379 shares beneficially owned and the 53,706,357 shares of common stock outstanding are tied to this same reference date in the filing.